1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar

 
• By Cathy Kelly

Nevertheless, the Pharmaceutical Research and Manufacturers of America announces enhancement of its drug pricing disclosures voluntary program, a Medicines Assistance Tool website that links to individual company sites, in response to the US rule.

Compliance

Pharmaceutical companies risk enforcement action under the Trump Administration’s final rule on list price disclosures in direct-to-consumer TV ads if they think it is enough to observe the Pharmaceutical Research and Manufacturers of America’s voluntary disclosure program, according to HHS Secretary Alex Azar.

The final rule requiring DTC TV ads to disclose list prices was released by the Centers for Medicare and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance